Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Marc Bourgault who wrote (4327)	5/18/1998 7:25:00 PM
From: PAL	Read Replies (2) of 6136

We are just noticing that Ms Wang's recommendation carries as much weight as yours and mine. I thought that AGPH will present its findings of AG3340 to the LA conference. AGPH is much further than ENMD yet that small biotech company could ride on the coattail of Genentech, while AGPH is heading south. To quote that famous Mr. Henry Lee: "something is wrong here". AGPH management should realize that stockholders invest in the company for the return on investment. If the horse is a dud, then people will get a different horse. Good Luck to every and all AGPH stockholders. PAL

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next